Naive T Cell Deplete Grafts for GVHD Prevention in Non-Malignant Diseases

Clinical trial NCT07660783 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07660783
Sponsor: Fred Hutchinson Cancer Center
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Bone Marrow Failure Hemoglobinopathies Primary Immune Deficiency (PID)Autoimmune Cytopenia Immune Dysregulation Hemophagocytic Lymphohistiocytosis (HLH)Non Malignant Disorders

Start date: 2026-09-01
Primary completion: 2031-09-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.